SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-242045
Filing Date
2021-08-10
Accepted
2021-08-10 17:26:59
Documents
1
Group Members
GENESIS VC PARTNERS XIV, LLCJEFFREY CROWEJON E. KOSSOWNVP ASSOCIATES, LLCPROMOD HAQUE

Document Format Files

Seq Description Document Type Size
1 SC 13G d186227dsc13g.htm SC 13G 110264
  Complete submission text file 0001193125-21-242045.txt   111956
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Subject) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92517 | Film No.: 211161166
SIC: 2834 Pharmaceutical Preparations

Mailing Address 525 UNIVERSITY AVENUE SUITE 800 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 800 PALO ALTO CA 94301 650-321-8000
Norwest Venture Partners XIV, LP (Filed by) CIK: 0001842721 (see all company filings)

IRS No.: 822560195 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G